Sara Ricardo

Scopus Author ID ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

International journal of molecular sciences

Cells

Cancers

Nature communications

Universidade do Porto Instituto de Investigação e Inovação em Saúde

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade do Porto Instituto de Investigação e Inovação em Saúde May 01 2017

Portugal

Assistant Researcher :: Differentiation and Cancer Group

Universidade do Porto Faculdade de Medicina May 04 2015

Portugal

Affiliate Professor :: Pathology and oncology department

Agency for Assessment and Accreditation of Higher Education May 15 2014

Portugal

Expert Evaluator

Universidade do Porto Instituto de Investigação e Inovação em Saúde Nov 01 2012 - Apr 30 2017

Portugal

Post-Doc Researcher :: Differentiation and Cancer Group

Instituto Politécnico de Bragança Escola Superior de Saúde de Bragança Apr 30 2014 - Feb 28 2016

Portugal

Course board of directors, Scientific coordinator and Assistent professor :: Diagnostic and Therapeutic Technologies Department

Instituto Politécnico de Saude do Norte Escola Superior de Saúde do Vale do Sousa Sep 01 2005 - Feb 28 2013

Portugal

Adjunt professor :: Diagnostic and Therapeutic Technologies

Universidade do Porto Instituto de Patologia e Imunologia Molecular Feb 01 2002 - Oct 31 2012

Portugal

Research member (Master and PhD Student) :: Breast pathology group

Universidade do Porto Instituto de Patologia e Imunologia Molecular Feb 01 2002 - Aug 27 2012

Portugal

Pathology technician :: Pathology Department

Instituto Superior de Ciências da Saúde Sep 01 2009 - Jun 30 2012

Portugal

Invited assistant professor

Publications

Mariana Nunes, Carla Bartosch, Miguel Henriques Abreu, Alan Richardson, Raquel Almeida, Sara Ricardo
Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options. Cells 13 (9) (2024)
Mariana Nunes, Carla Bartosch, Miguel Henriques Abreu, Alan Richardson, Raquel Almeida, Sara Ricardo
Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options. Cells 13 (9) (2024)
Mariana Nunes, Carla Bartosch, Miguel Henriques Abreu, Alan Richardson, Raquel Almeida, Sara Ricardo
Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options. Cells 13 (9) (2024)
Doroteya Raykova, Despoina Kermpatsou, Tony Malmqvist, Philip J Harrison, Marie Rubin Sander, Christiane Stiller, Johan Heldin, Mattias Leino, Sara Ricardo, Anna H Klemm, Leonor David, Ola Spjuth, Kalyani Vemuri, Anna Dimberg, Anders Sundqvist, Maria Norlin, Axel Klaesson, Caroline Kampf, Ola Söderberg
Author Correction: A method for Boolean analysis of protein interactions at a molecular level. Nature communications 14 (1) (2023)
Mariana Nunes, Diana Duarte, Nuno Vale, Sara Ricardo
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma. Cancers 14 (18) (2022)
Mariana Nunes, Francisca Pacheco, Ricardo Coelho, Dina Leitão, Sara Ricardo, Leonor David
Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer. International journal of molecular sciences 23 (3) (2022)
Diana Luísa Almeida-Nunes, Ana Mendes-Frias, Ricardo Silvestre, Ricardo Jorge Dinis-Oliveira, Sara Ricardo
Immune Tumor Microenvironment in Ovarian Cancer Ascites. International journal of molecular sciences 23 (18) (2022)
Doroteya Raykova, Despoina Kermpatsou, Tony Malmqvist, Philip J Harrison, Marie Rubin Sander, Christiane Stiller, Johan Heldin, Mattias Leino, Sara Ricardo, Anna H Klemm, Leonor David, Ola Spjuth, Kalyani Vemuri, Anna Dimberg, Anders Sundqvist, Maria Norlin, Axel Klaesson, Caroline Kampf, Ola Söderberg
A method for Boolean analysis of protein interactions at a molecular level. Nature communications 13 (1) (2022)
Sara Ricardo, Pedro Canão, Diana Martins, Ana Cristina Magalhães, Marina Alessandra Pereira, Ulysses Ribeiro-Junior, Evandro Sobroza de Mello, Venâncio A Alves, Regina Pinto, Dina Leitão, Georgina Alves, Rute Oliveira, Joana Wilton, Susete Costelha, Diana Meireles, Didier Cabanes, Leonor David, Fernando C. Schmitt
Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression. Cancers 14 (11) (2022)
Ana Cristina Magalhães, Sara Ricardo, Ana C Moreira, Mariana Nunes, Margarida Tavares, Ricardo J Pinto, Maria Salomé Gomes, Luísa Pereira
InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays. Pathogens (Basel, Switzerland) 11 (3) (2022)
Diana Duarte, Mariana Nunes, Sara Ricardo, Nuno Vale
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action. Biomolecules 12 (10) (2022)
Mariana Nunes, Miguel Henriques Abreu, Carla Bartosch, Sara Ricardo
Recycling the Purpose of Old Drugs to Treat Ovarian Cancer. International journal of molecular sciences 21 (20) (2020)
Ricardo Coelho, Lara Marcos-Silva, Nuno Mendes, Daniela Pereira, Catarina Brito, Francis Jacob, Catharina Steentoft, Ulla Mandel, Henrik Clausen, Leonor David, Sara Ricardo
Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours. International journal of molecular sciences 19 (7) (2018)
Sara Ricardo, Lara Marcos-Silva, Leonor David
Mucin carriers of TF in ovarian cancer. Journal of cancer research and clinical oncology 142 (8) (2016)

Sara Ricardo

Publication Activity (10 Years)

Top Topics

Top Venues